Compositions and methods for improving viral vector efficiency
US-2018318447-A1 · Nov 8, 2018 · US
Peptides with viral infection enhancing properties and their use
US10596264B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10596264-B2 |
| Application number | US-201214130285-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 28, 2012 |
| Priority date | Jun 30, 2011 |
| Publication date | Mar 24, 2020 |
| Grant date | Mar 24, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to LAH4 peptides and functional derivatives thereof and their use for improving transduction efficiency of viruses into target cells.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for promoting the infection of an eukaryotic cell by a virus or a viral particle, comprising contacting a cell or a subject in need thereof with the virus or viral particle and with a peptide having the sequence of SEQ ID NO: 14. 2. An isolated peptide selected in the group consisting of SEQ ID NOs: 8-27. 3. A method for infecting eukaryotic cells with a virus or a viral particle or for increasing the eff…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10596264B2 cover?
- The invention relates to LAH4 peptides and functional derivatives thereof and their use for improving transduction efficiency of viruses into target cells.
- Who is the assignee on this patent?
- Fenard David, Kichler Antoine, Martin Samia, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07K14/47. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).